Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Merus N.V. Logo
A clinical-stage oncology company developing multispecific antibody therapeutics for cancer.
United States of America
MRUS
MESOBLAST LTD Logo
Develops allogeneic cellular medicines for severe inflammatory conditions.
United States of America
MESO
Develops digital solutions for the health sector with a focus on medical weight loss.
Sweden
MBOLIC
MetaVia Inc. Logo
A clinical-stage biotech company developing drugs for cardiometabolic diseases.
United States of America
MTVA
Metsera, Inc. Logo
Clinical-stage biopharma developing peptide therapies for obesity and metabolic diseases.
United States of America
MTSR
Mezzion Pharma Co., Ltd. Logo
Develops novel therapeutics for rare diseases, focusing on Fontan circulation.
South Korea
140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO for the R&D and production of APIs and intermediates.
South Korea
432980
Milestone Pharmaceuticals Inc. Logo
Clinical-stage biopharma developing a nasal spray for heart rhythm disturbances.
United States of America
MIST
MIMEDX GROUP, INC. Logo
Develops placental tissue allografts for wound care, surgical, and burn treatment.
United States of America
MDXG
Mind Medicine (MindMed) Inc. Logo
A clinical-stage biopharmaceutical company developing novel treatments for brain health disorders.
United States of America
MNMD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.